Notes to the Financial Statements Note 1: Segment Information continued Reconciliation of statutory results to underlying results 9 Capital expenditure excludes PPE and intangible assets acquired in connection with the acquisition of CSL Vifor (Note 2). Year ended 30 June (US$m) Statutory results Adjustments Underlying results3 Nature of adjustments 2023 2022 2023 2022 2023 2022 Gross profit 6,844 5,732 406 2 7,250 5,734 • $235m (2022: $2m) amortisation of acquired IP (commercialised) of which $181m is attributable to CSL Limited shareholders (2022: $2m)5 • $169m (2022: nil) unwind of inventory fair value uplift of which $122m is attributable to CSL Limited shareholders (2022: nil)6 • $2m (2022: nil) acquisition and integration costs attributable to the CSL Limited shareholders Operating profit 3,069 2,927 588 155 3,657 3,082 Consistent with adjustments to gross profit coupled with the following: • Impairment of acquired IP (in development). Adjustments were nil for 2023 (2022: $113m attributable to CSL Limited shareholders)5 • $182m (2022: $40m) acquisition and integration costs attributable to CSL Limited shareholders7 Profit before tax 2,663 2,780 588 155 3,251 2,935 • Consistent with adjustments made to operating results NPAT/NPATA4 2,244 2,255 503 126 2,747 2,381 • Consistent with adjustments made to profit before tax, net of tax impact including $71m attributable to CSL Limited shareholders (2022: $29m) NPAT/NPATA4 attributable to CSL Limited shareholders 2,194 2,255 416 126 2,610 2,381 • Share of NPATA4 adjustments attributable to CSL Limited shareholders (after noncontrolling interests) Basic earnings/ NPATA4 per share (US$) 4.55 4.81 0.86 0.27 5.41 5.08 • Calculated based on NPATA4 attributable to CSL Limited shareholders divided by the weighted average number of shares during the period (2023: 482,173,148; 2022: 468,754,857) Segment assets and liabilities Segment assets for the year ended 30 June 2023 include goodwill acquired in connection with the acquisition of CSL Vifor which has been allocated across the Group’s segments (Note 2). CSL Behring US$m CSL Seqirus US$m CSL Vifor US$m Intersegment Elimination US$m Consolidated Entity US$m 2023 2022 2023 2022 2023 2022 2023 2022 2023 2022 Segment assets 34,535 25,882 5,908 3,041 10,742 – (14,951) (577) 36,234 28,346 Segment liabilities 15,782 12,665 3,696 1,618 2,155 – (3,225) (514) 18,408 13,769 Other segment information – capital expenditure Cash payments for property, plant and equipment (PPE) 869 921 326 158 33 – – – 1,228 1,079 Cash payments for intangibles 83 162 292 7 89 – – – 464 169 Total capital expenditure9 952 1,083 618 165 122 – – – 1,692 1,248 CSL Limited Annual Report 2022/23 120
RkJQdWJsaXNoZXIy MjE2NDg3